These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 24919759
41. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT. Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T. Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489 [Abstract] [Full Text] [Related]
42. [Investigation of trends in patients with pollinosis by using web site and the correlation access number and Japanese cedar pollen counts]. Ikeda N, Monden A, Ogino S. Arerugi; 2005 May; 54(5):464-70. PubMed ID: 16043972 [Abstract] [Full Text] [Related]
43. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study. Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S. Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940 [Abstract] [Full Text] [Related]
44. Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis. Kikuoka H, Kouzaki H, Matsumoto K, Arai H, Yamamoto S, Tojima I, Shimizu S, Miyashita H, Ogawa Y, Osada T, Okano M, Yuta A, Shimizu T. Clin Immunol; 2020 Jan; 210():108310. PubMed ID: 31743749 [Abstract] [Full Text] [Related]
45. [Japanese cedar pollinosis in children in our allergy clinic]. Masuda S, Takeuchi K, Yuta A, Okawa C, Ukai K, Sakakura Y. Arerugi; 1998 Nov; 47(11):1182-9. PubMed ID: 9893335 [Abstract] [Full Text] [Related]
46. A clinical study of Japanese cedar (Cryptomeria japonica) pollen-induced asthma. Maeda Y, Akiyama K, Shida T. Allergol Int; 2008 Dec; 57(4):413-7. PubMed ID: 18946237 [Abstract] [Full Text] [Related]
47. A 13-year study of Japanese cedar pollinosis in Japanese schoolchildren. Ozasa K, Hama T, Dejima K, Watanabe Y, Hyo S, Terada T, Araki N, Takenaka H. Allergol Int; 2008 Jun; 57(2):175-80. PubMed ID: 18427167 [Abstract] [Full Text] [Related]
48. Effect of Lactobacillus plantarum YIT 0132 on Japanese cedar pollinosis and regulatory T cells in adults. Suzuki S, Kubota N, Kakiyama S, Miyazaki K, Sato K, Harima-Mizusawa N. Allergy; 2020 Feb; 75(2):453-456. PubMed ID: 31370110 [No Abstract] [Full Text] [Related]
49. Investigation of the sensitization rate for gibberellin-regulated protein in patients with Japanese cedar pollinosis. Mori Y, Okazaki F, Momma K, Narita H, Kondo Y. Allergol Immunopathol (Madr); 2022 Feb; 50(2):89-92. PubMed ID: 35257550 [Abstract] [Full Text] [Related]
50. Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollen. Fujimura T, Futamura N, Midoro-Horiuti T, Togawa A, Goldblum RM, Yasueda H, Saito A, Shinohara K, Masuda K, Kurata K, Sakaguchi M. Allergy; 2007 May; 62(5):547-53. PubMed ID: 17441795 [Abstract] [Full Text] [Related]
51. High contribution contrast between the genes of eosinophil peroxidase and IL-4 receptor alpha-chain in Japanese cedar pollinosis. Nakamura H, Miyagawa K, Ogino K, Endo T, Imai T, Ozasa K, Motohashi Y, Matsuzaki I, Sasahara S, Hatta K, Eboshida A. J Allergy Clin Immunol; 2003 Dec; 112(6):1127-31. PubMed ID: 14657871 [Abstract] [Full Text] [Related]
52. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A. Int Arch Allergy Immunol; 2015 Dec; 166(3):177-88. PubMed ID: 25895909 [Abstract] [Full Text] [Related]
53. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells. Masuda K. Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609 [Abstract] [Full Text] [Related]
54. Studies of prevalence of Japanese cedar pollinosis among the residents in a densely cultivated area. Ishizaki T, Koizumi K, Ikemori R, Ishiyama Y, Kushibiki E. Ann Allergy; 1987 Apr 18; 58(4):265-70. PubMed ID: 3565861 [Abstract] [Full Text] [Related]
55. [Epidemiologic study of Alnus sieboldiana Matsumura (alder) pollinosis in Ashiya city]. Yoshimura S, Ogasawara H, Nakahara T, Fujitani T. Arerugi; 1995 Jun 18; 44(6):602-8. PubMed ID: 7668998 [Abstract] [Full Text] [Related]
56. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy. Fujimura T, Kawamoto S. Allergol Int; 2015 Oct 18; 64(4):312-20. PubMed ID: 26433527 [Abstract] [Full Text] [Related]
57. [Prevalence of sensitization of Japanese cedar pollen in children from infancy to adolescence]. Masuda S, Fujisawa T, Iguchi K, Atsuta J, Noma Y, Nagao M, Nambu M, Suehiro Y, Kamesaki S, Terada A, Mizuno M, Shimizu S, Tohda Y. Arerugi; 2006 Oct 18; 55(10):1312-20. PubMed ID: 17072111 [Abstract] [Full Text] [Related]
58. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis]. Yuta A, Miyamoto Y, Ogihara H, Hattori R, Okubo K. Arerugi; 2009 Feb 18; 58(2):124-32. PubMed ID: 19329875 [Abstract] [Full Text] [Related]
59. An analysis of factors associated with compliance and dropout of sublingual immunotherapy on Japanese cedar pollinosis patients. Imanaka T, Sato I, Kawasaki Y, Kanazawa Y, Kawakami K. Int Forum Allergy Rhinol; 2019 Jun 18; 9(6):615-623. PubMed ID: 31173675 [Abstract] [Full Text] [Related]
60. Analysis of natural history of Japanese cedar pollinosis. Okawa T, Konno A, Yamakoshi T, Numata T, Terada N, Shima M. Int Arch Allergy Immunol; 2003 May 18; 131(1):39-45. PubMed ID: 12759488 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]